You would not be surprised to know that there are many experiments and trials going on to test the efficacy of drugs that are supposed to treat obesity and overweight problems. In one could turn out to be very successful drug release, Britain’s GW Pharmaceuticals Plc announced on Tuesday that human trials of an experimental treatment for obesity derived from cannabis are scheduled to begin in the second half of this year. It is noticeable here that cannabis is commonly associated with stimulating hunger.

It has been also reported that several other companies, such as Sanofi-Aventis, are also working on new drugs that will switch off the brain circuits–the circuits that are responsible for making people hungry when they smoke cannabis. However, the company GW Pharmaceuticals Plc is saying that it has been successful in deriving a treatment from cannabis that could help suppress hunger. It is quite a startling statement, but we can’t comment on this issue till we get the results of human trials that the company has just scheduled.

We can easily understand the urgency and the importance of these trials, as many companies world over are trying to find a drug that can cater to the needs of tackling obesity with any side-effects. However, drugs that are be used in human medication need proper monitoring and have to undergo a series of steps that sometimes take many years to be completed. So, we can guess that it is a good step forward from the company, but we can’t comment on the application and the efficacy of the drug till we get some clear results of the trials. We expect that something positive will come out from these trials, for, the world needs something special in case of drugs dealing to cure obesity. We will surely need to wait and watch what happens and how it comes out.